# clm_E7C205B81C1E

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 4,234,000,000 United States dollar  
valid_from: 2025-09-30  
valid_to: 2026-03-31  
published: 2025-11-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_CC42DDED77FE  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 4,234,000,000 United States dollar", as of 2025-09-30 (until 2026-03-31). Claim clm_E7C205B81C1E, https://asof.is/claim/clm_E7C205B81C1E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2025, filed 2025-11-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000031015825000059/0000310158-25-000059-index.htm (primary, SEC EDGAR 10-Q Q3 FY2025, published 2025-11-05)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 4,048,000,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_E7C205B81C1E](/claim/clm_E7C205B81C1E.md) | [clm_6E0F8CB5C8F7](/claim/clm_6E0F8CB5C8F7.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.